Tower Research Capital LLC (TRC) - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 53 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$8,000
-27.3%
6,212
-20.7%
0.00%
Q2 2020$11,000
-50.0%
7,835
+30.0%
0.00%
-100.0%
Q2 2019$22,000
+57.1%
6,027
+348.8%
0.00%0.0%
Q1 2019$14,000
+100.0%
1,343
+117.3%
0.00%0.0%
Q3 2018$7,000
+75.0%
618
+154.3%
0.00%
Q1 2018$4,000
+300.0%
243
+224.0%
0.00%
Q4 2017$1,000
-66.7%
75
-62.1%
0.00%
Q3 2017$3,000
-62.5%
198
-72.0%
0.00%
-100.0%
Q3 2016$8,000
-46.7%
708
-55.2%
0.00%0.0%
Q2 2016$15,0001,5820.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
BVF INC/IL 615,384$8,332,0001.29%
RTW INVESTMENTS, LP 250,000$3,385,0000.71%
Monashee Investment Management LLC 100,000$1,354,0000.57%
PARSONS CAPITAL MANAGEMENT INC/RI 275,728$3,733,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 175,000$2,370,0000.40%
TIEDEMANN ADVISORS, LLC 362,049$4,902,0000.36%
Morse Asset Management, Inc 63,700$862,0000.28%
Private Capital Advisors, Inc. 56,250$762,0000.25%
Crestline Management, LP 98,581$1,335,0000.18%
SECTORAL ASSET MANAGEMENT INC 112,500$1,523,0000.17%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders